AZ

Anjie Zhengjuan

Description

Anjie Zhengjuan offers securities, asset management, and enterprise services.

Investor Profile

Anjie Zhengjuan has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Clinical Trials, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Health Care
  • Medical
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Anjie Zhengjuan frequently co-invest with?

Sinopharm Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Qingsong Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
BC
North America, California, United States, Palo Alto
Co-Investments: 1
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Quan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CC
Asia, Liaoning, China, Chaoyang
Co-Investments: 1

What are some of recent deals done by Anjie Zhengjuan?

MEDx

Suzhou, Jiangsu, China

MEDx provides precision medicine solutions to improve clinical development.

BiotechnologyClinical TrialsHealth CareMedicalPrecision Medicine
Series BSep 28, 2020
Amount Raised: $51,380,672